Sessa Capital (Master), L.P.

Insider Reports History

Location
New York, NY
Signature
/s/ John Petry, for Sessa Capital (Master), L.P., By: Sessa Capital GP, LLC, its general partner, By: John Petry, as manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sessa Capital (Master), L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
SAB Biotherapeutics, Inc. Director Common Stock 2,198,457 $3,847,299 $1.75 29 Sep 2025 Direct
SAB Biotherapeutics, Inc. Director Series B Convertible Preferred Stock 211,100 29 Sep 2025 Direct
SAB Biotherapeutics, Inc. Director Warrants (right to buy) 114,250 22 Jul 2025 Direct
Provention Bio, Inc. 10%+ Owner Common Stock 0 $24.32 27 Apr 2023 Direct

Insider Reports Filed by Sessa Capital (Master), L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SABS SAB Biotherapeutics, Inc. 29 Sep 2025 2 +$3,045,000 4 Director 01 Oct 2025, 16:06
SABS SAB Biotherapeutics, Inc. 22 Jul 2025 3 $0 4 Director 24 Jul 2025, 16:31
SABS SAB Biotherapeutics, Inc. 24 Nov 2023 3 -$2,889,000 4 Director 28 Nov 2023, 16:05
SABS SAB Biotherapeutics, Inc. 10 Nov 2023 1 +$13,269,000 4/A Director 15 Nov 2023, 16:30
SABS SAB Biotherapeutics, Inc. 23 Oct 2023 2 +$16,269,000 4 Director 24 Oct 2023, 17:33
SABS SAB Biotherapeutics, Inc. 02 Oct 2023 0 $0 3 Director 10 Oct 2023, 16:24
/report/000106299323009669-sessa-capital-master-l-p-2023-04-27 Provention Bio, Inc. 27 Apr 2023 1 $0 4 10%+ Owner 28 Apr 2023, 16:18
/report/000106299323009486-sessa-capital-master-l-p-2023-04-20 Provention Bio, Inc. 20 Apr 2023 2 $0 4 10%+ Owner 24 Apr 2023, 16:18
/report/000106299323009310-sessa-capital-master-l-p-2023-04-14 Provention Bio, Inc. 14 Apr 2023 3 -$13.68 4 10%+ Owner 18 Apr 2023, 20:57
/report/000106299323008724-sessa-capital-master-l-p-2023-03-31 Provention Bio, Inc. 31 Mar 2023 2 $0 4 10%+ Owner 04 Apr 2023, 20:10
/report/000106299323001185-sessa-capital-master-l-p-2023-01-18 Provention Bio, Inc. 18 Jan 2023 1 -$28,200,000 4 10%+ Owner 20 Jan 2023, 15:10
/report/000106299322016227-sessa-capital-master-l-p-2022-07-07 Provention Bio, Inc. 07 Jul 2022 0 $0 3 10%+ Owner 11 Jul 2022, 17:39